Cite
HARVARD Citation
Wooten, D. et al. (n.d.). Baseline amyloid and tau PET imaging characteristics in the ongoing phase 2 study of tilavonemab in early Alzheimer's disease. Alzheimer's & dementia. p. n/a. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Wooten, D. et al. (n.d.). Baseline amyloid and tau PET imaging characteristics in the ongoing phase 2 study of tilavonemab in early Alzheimer's disease. Alzheimer's & dementia. p. n/a. [Online].